Download Citation
Article Source:
A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial of the TLR-3 Agonist Rintatolimod in Severe Cases of Chronic Fatigue Syndrome
Strayer DR,
Carter WA,
Stouch BC,
Stevens SR,
Bateman L,
et al.
(2012)
A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial of the TLR-3 Agonist Rintatolimod in Severe Cases of Chronic Fatigue Syndrome.
PLOS ONE 7(3): e31334.
https://doi.org/10.1371/journal.pone.0031334